한글목차

세계 대사체학 시장 규모는 2024년 164억 달러에서 예측 기간 동안 연평균 13.1% 성장하여 2029년 말에는 302억 달러에 달할 것으로 예상됩니다.

분리 기술 부문은 2024년 83억 달러에서 연평균 13.1% 성장하여 2029년 말에는 154억 달러에 달할 것으로 예상됩니다. 검출 기술 부문은 2024년 80억 달러에서 연평균 13.0% 성장하여 2029년 말에는 148억 달러에 달할 것으로 예측됩니다.

세계 대사체학 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신흥 기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 개요
• 대사체학 개요
• 분리 기술
• 검출 기술
• 대사물과 그 응용
• 연구개발과 규제 승인
• 공급망 분석

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 시장 과제

제4장 신기술과 개발

• 임상시험 분석
• 연구 유형별
• 상황별
• 성별
• 개입별
• 취득 특허
• 특허 분석

제5장 시장 세분화 분석

• 세분화 내역
• 대사체학 시장 : 제품별
• 세계 시장 분석과 예측
• 분리 기술
• 검출 기술
• 대사체학 시장 : 적응증별
• 세계 시장 분석과 예측
• 암
• 심혈관질환
• 신경학적 장애
• 선천성 대사이상
• 기타
• 대사체학 시장 : 용도별
• 세계 시장 분석과 예측
• 바이오마커 발견
• Drug Discovery
• 독성 시험
• 영양유전체학
• 기능유전체학
• 기타
• 대사체학 시장 : 지역별
• 세계
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 기업 점유율 분석
• 전략 분석
• M&A
• 벤처 캐피털 자금 조달

제7장 부록

• 조사 방법
• 약어
• 정보 출처
• 기업 개요
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• BRUKER
• DANAHER CORP.
• MERCK KGAA
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• WATERS CORP.

영문목차

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

The global market for separation techniques for metabolomics technologies is expected to grow from $8.3 billion in 2024 and is projected to reach $15.4 billion by the end of 2029, at a CAGR of 13.1% during the forecast period of 2024 to 2029.

The global market for detection techniques for metabolomics technologies is expected to grow from $8.0 billion in 2024 and is projected to reach $14.8 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.

Report Scope

This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.

Report Includes

• 32 data tables and 39 additional tables
• An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
• Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
• Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
• Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
• A look at ESG trends
• Information on developments in R&D, clinical trials, emerging technologies, and economic trends
• Analysis of key companies' market shares, proprietary technologies, patents, and alliances
• Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Overview of Metabolomics
• Separation Techniques
• Detection Techniques
• Metabolites and Their Applications
• R&D and Regulatory Approval
• Supply Chain Analysis

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Technological Advancements
• Increasing Healthcare Expenditure
• Expanding Applications Across Industries
• Market Restraints
• High Cost of Instruments and Services
• Complexity of Data Analysis
• Standardization and Quality Control Challenges
• Limited Biomarker Validation and Clinical Utility
• Market Opportunities
• Precision Medicine and Personalized Healthcare
• Drug Discovery and Development
• Biomarker Discovery and Validation
• Nutritional Profiling and Functional Foods
• Environmental Monitoring and Toxicology
• Market Challenges
• Data Complexity and Interpretation
• Standardization and Quality Assurance
• Biomarker Validation and Clinical Translation
• Technological Limitations and Costs
• Regulatory and Ethical Considerations

Chapter 4 Emerging Technologies and Developments

• Introduction
• Clinical Trial Analysis
• By Study Type
• By Status
• By Gender
• By Interventions
• Granted Patents
• Introduction
• Patent Analysis

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Metabolomics Market, by Product
• Global Market Analysis and Forecast
• Separation Techniques
• Detection Techniques
• Metabolomics Market, by Indication
• Global Market Analysis and Forecast
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Diseases Indication
• Metabolomics Market, by Application
• Global Market Analysis and Forecast
• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Others
• Geographic Breakdown
• Metabolomics Market, by Region
• Global
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Company Share Analysis
• Strategic Analysis
• Mergers and Acquisitions
• Venture Capital Funding

Chapter 7 Appendix

• Methodology
• Sources
• Acronyms
• Definitions/Taxonomy
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• BRUKER
• DANAHER CORP.
• MERCK KGAA
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• WATERS CORP.